Suggestions
Dave Sutherland
Vice President, Finance at Catamaran Bio
Professional Background
Dave Sutherland is a dedicated finance professional whose extensive experience spans various key positions within the biopharmaceutical and financial industries. Currently, he serves as the Vice President of Finance at Catamaran Bio, leading financial strategy to foster growth and innovation in the biotech sector. His career is distinguished by a series of progressively responsible roles, particularly within Akebia Therapeutics, where he was instrumental in the company's financial planning and analysis as the Senior Director. Prior to that, he played a significant role in the merger of Akebia and Keryx Biopharmaceuticals, serving initially as the Senior Director of Finance & Accounting and previously as the Director of Accounting, Controller.
Having worked with global leaders at PwC (PricewaterhouseCoopers), Dave's foundational experience as an Audit Manager, Senior Associate, and Associate equipped him with a unique perspective and comprehensive skills in accounting and financial management specialized in various industries. His professional journey showcases his commitment to excellence and strategic thinking in finance, making him a valuable asset in any organization he joins.
Education and Achievements
Dave proudly holds a Master of Science in Accounting from Boston College, where he honed his specialized knowledge in accounting and finance. Complementing this advanced degree, he also earned a Bachelor of Science in Finance and Accounting from the prestigious Boston College Carroll School of Management. His academic background was furthered through studies in Business Administration and Management at Universidad Carlos III de Madrid, a renowned institution that has equipped him with a broad understanding of business dynamics in an international context.
Through his education, Dave has not only acquired theoretical knowledge but has also cultivated analytical and practical skills essential for successful financial oversight and management. He integrates these competencies effectively within his organizations, enabling sustainable growth and enhanced financial performance.
Notable Achievements
Throughout his impressive career, Dave has demonstrated exemplary leadership skills and a strong aptitude for financial strategy. His successful tenure at Keryx Biopharmaceuticals culminated in a significant merger with Akebia Therapeutics, a notable industry event that required careful financial planning and execution. His role significantly shaped the financial trajectory of both companies, reflecting his capability in high-stakes environments.
At PwC, he distinguished himself in auditing, where he ensured compliance and accurate financial reporting for various clients, providing them with peace of mind and enhancing their operational efficiencies. This experience became the bedrock for his later roles in finance, where precision and deep analytical skills are critical to driving business success. His journey in finance has been marked by consistent growth and increased responsibility, underscoring his commitment to the field and his pursuit of excellence.